论文部分内容阅读
对我院４５例确诊为中、重度细菌感染住院患者进行了亚胺培南／西司他丁与头孢他啶疗效费用分析比较研究。结果表明：２组病例有效率、死亡率无显著性差异；头孢他啶组较亚胺培南／西司他丁组疗程明显延长。亚胺培南／西司他丁每日所需费用明显高于头孢他啶；治疗结束时，前者全部费用并未超过后者；全部住院费用无明显差异。作者认为：决定２种药物全部费用的因素，除与药物单价和每日费用有关，还与药物疗程密切相关。选用药物抗菌作用越强，用药时间即相应缩短，住院时间必然缩短；最终患者住院费用降低
In our hospital 45 cases were diagnosed as moderate and severe bacterial infections in patients with imipenem / cilastatin and ceftazidime efficacy of the comparative analysis. The results showed that there was no significant difference between the two groups in the efficiency and mortality; the course of ceftazidime in the imipenem / cilastatin group was significantly prolonged. The daily cost of imipenem / cilastatin was significantly higher than that of ceftazidime; at the end of treatment, the former did not exceed the latter’s full cost; there was no significant difference in the total hospitalization costs. The author believes that the factors that determine the full cost of the two drugs, in addition to the unit price of drugs and the daily cost, are also closely related to medication. The stronger the antimicrobial effect of the selected drugs, the shorter the time of treatment, the shorter the length of hospitalization; the lower the cost of hospitalization for the final patients